HHC
IRWD icon

Hutchin Hill Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Hutchin Hill Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-221,009
Closed -$2.92M – 533
2017
Q3 		$2.92M Buy
221,009
+161,309
+270% +$2.22M 0.11% 185
2017
Q2 		$944K Buy
+59,700
New +$867K 0.03% 517
2015
Q1 		– Sell
-87,532
Closed -$1.12M – 733
2014
Q4 		$1.12M Sell
87,532
-121,418
-58% -$1.39M 0.04% 313
2014
Q3 		$2.27M Hold
208,950
– – 0.09% 233
2014
Q2 		$2.68M Buy
208,950
+29,850
+17% +$325K 0.12% 113
2014
Q1 		$1.85M Buy
+179,100
New +$2.01M 0.1% 219

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hutchin Hill Capital's IRWD Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2017, closing a stake of 221,009 shares — an estimated $2.92M sold.

Hutchin Hill Capital first reported a position in IRWD in Q1 2014 and held it in 6 quarters. The position peaked at $2.92M in Q3 2017. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

  • Hutchin Hill Capital reported no remaining Ironwood Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 221,009 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $2.92M.
  • Hutchin Hill Capital first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 6 quarters.
  • Hutchin Hill Capital's Ironwood Pharmaceuticals position peaked at $2.92M in Q3 2017.
  • 158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.